Skip to content

Effect of esketamine on emergence agitation and negative postoperative behavioural outcomes after minor surgery in children

Effect of esketamine on emergence agitation and negative postoperative behavioural outcomes after minor surgery in children

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098410
Enrollment
Unknown
Registered
2025-03-07
Start date
2025-03-11
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emergence agitation

Interventions

esmketamine group ( group S):Group S received intravenous injection of esmketamine 0. 3 mg / kg
control group ( group C):group C was injected with equal volume of normal saline intravenously

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: (1) the American Society of Anesthesiologist (ASA) Physical Status classifcation ?-? (2) children aged 3–10 years,weighing between 10 and 50 kg

Exclusion criteria

Exclusion criteria: (1) Allergy to related anesthetic drugs (2) History of acute upper respiratory tract infection within 14 days prior to surgery. (3) Severe organic lesions of vital organs such as heart, liver, and kidney (4) Presence of psychiatric and neurological diseases that hindered cooperation (5) History of premature birth ,congenital, hereditary, psychiatric or epilepsy disorders (6) History of anaesthesia or sedation recently (7) Severe preoperative anxiety of parents

Design outcomes

Primary

MeasureTime frame
Postoperative behavioral change score;pain score;The paediatric anaesthesia emergence delirium (PAED) scores;

Secondary

MeasureTime frame
Vital signs at the time of extubation;Vital signs when exiting the resuscitation room;extubation time;PACU residence time;Length of hospital stay;the number of additional cases of propofol in recovery period,;the number of additional cases of analgesics in recovery period;The occurrence of adverse events in recovery period;

Countries

China

Contacts

Public ContactXiang-yun Feng

The First Affiliated Hospital of Zhengzhou University

1138585816@qq.com+86 150 3837 3584

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026